Nakamura K, Nakamachi T, Endo K, Ito K, Machida T, Oka T, Hori M, Ishizaka K, Shioda S
Department of Anatomy, Showa University School of Medicine, Shinagawaku, Tokyo, Japan; Department of Urology, Kanto Central Hospital, Setagayaku, Tokyo, Japan.
Andrologia. 2014 Jun;46(5):465-71. doi: 10.1111/and.12102. Epub 2013 Apr 27.
Pituitary adenylate cyclase-activating peptide (PACAP) is a neuropeptide expressed in the central nervous system and peripheral organs. Previous studies revealed the role and distribution of PACAP in the rodent testis, however, its presence in the human testis and in testicular germ cell tumors is not known. We used RT-PCR and immunohistological observations to investigate whether human testicular tissue and testicular germ cell tumors contain PACAP. The mRNAs for PACAP and its receptors were detected in total RNA extracted from human testes. PACAP immunoreactivity was observed in spermatogonia and spermatids from normal testes. In contrast, diffuse PACAP immunopositivity was observed in seminoma tumor cells, while only faint immunoreactivity was observed in embryonal carcinoma cells. Our data suggest that PACAP may play a role in human spermatogenesis and in testicular germ cell tumor development.
垂体腺苷酸环化酶激活肽(PACAP)是一种在中枢神经系统和外周器官中表达的神经肽。先前的研究揭示了PACAP在啮齿动物睾丸中的作用和分布,然而,其在人类睾丸和睾丸生殖细胞肿瘤中的存在情况尚不清楚。我们使用逆转录聚合酶链反应(RT-PCR)和免疫组织学观察来研究人类睾丸组织和睾丸生殖细胞肿瘤中是否含有PACAP。在从人类睾丸提取的总RNA中检测到了PACAP及其受体的信使核糖核酸(mRNA)。在正常睾丸的精原细胞和精子细胞中观察到了PACAP免疫反应性。相比之下,在精原细胞瘤肿瘤细胞中观察到弥漫性PACAP免疫阳性,而在胚胎癌细胞中仅观察到微弱的免疫反应性。我们的数据表明,PACAP可能在人类精子发生和睾丸生殖细胞肿瘤发展中发挥作用。